DrugPatentWatch Database Preview

Details for Patent: 7,396,841

« Back to Dashboard

Which drugs does patent 7,396,841 protect, and when does it expire?

Patent 7,396,841 protects PREVACID IV and is included in one NDA.

Protection for PREVACID IV has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has six patent family members in five countries.

This patent has expired prematurely due to non-payment of maintenance fees. See details below.

Summary for Patent: 7,396,841

Title:	Injections
Abstract:	An injectable composition comprises a benzimidazole compound having an antiulcer action and a strong alkali (e.g., an alkali metal hydroxide such as sodium hydroxide) in a proportion of about 1 equivalent of the latter relative to 1 mol of the former, and is substantially free from a nonaqueous solvent. The injectable composition may comprise N-methylglucamine, and a saccharide (such as mannitol). The injectable composition may be a freeze-dried preparation. The freeze-dried preparation is dissolvable in or dilutive with a distilled water for injection or an infusion solution without a nonaqueous solvent. The injectable composition is useful as an antiulcer agent.
Inventor(s):	Doen; Takayuki (Suita, JP), Nagao; Masao (Kashiba, JP), Asakawa; Naoki (Takatsuki, JP), Takechi; Nobuyuki (Osaka, JP)
Assignee:	Takeda Pharmaceutical Company Limited (Osaka, JP)
Application Number:	10/344,805
Patent Claim Types: see list of patent claims	Composition; Compound; Formulation; Process; Use;

Drugs Protected by US Patent 7,396,841

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Takeda Pharms Na	PREVACID IV	lansoprazole	INJECTABLE;INTRAVENOUS	021566-001	May 27, 2004		DISCN	Yes	No					Y

Foreign Priority and PCT Information for Patent: 7,396,841

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Japan	2000-248468	Aug 18, 2000

PCT Information
PCT Filed	August 17, 2001	PCT Application Number:	PCT/JP01/07075
PCT Publication Date:	February 28, 2002	PCT Publication Number:	WO02/15908

International Family Members for US Patent 7,396,841

Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	7875501
Canada	2419067
European Patent Office	1310252
Japan	2002128675